Statement Of Cash Flows

Chiome Bioscience Inc. - Filing #7550870

Concept As at
2023-06-30
2023-01-01 to
2023-06-30
As at
2022-12-31
As at
2022-06-30
2022-01-01 to
2022-06-30
As at
2021-12-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-661,150,000 JPY
-768,500,000 JPY
Depreciation
611,000 JPY
762,000 JPY
Decrease (increase) in trade receivables
18,308,000 JPY
-42,946,000 JPY
Decrease (increase) in inventories
11,739,000 JPY
-6,984,000 JPY
Increase (decrease) in trade payables
4,197,000 JPY
16,280,000 JPY
Subtotal
-589,373,000 JPY
-656,355,000 JPY
Income taxes paid
-5,010,000 JPY
-3,240,000 JPY
Other, net
7,910,000 JPY
-20,517,000 JPY
Net cash provided by (used in) operating activities
-595,281,000 JPY
-660,225,000 JPY
Interest paid
-910,000 JPY
-645,000 JPY
Cash flows from operating activities
Increase (decrease) in accounts payable - other
710,000 JPY
8,985,000 JPY
Cash flows from operating activities
Cash flows from investing activities
Proceeds from sale of property, plant and equipment
82,000 JPY
JPY
Net cash provided by (used in) investing activities
82,000 JPY
JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Proceeds from short-term borrowings
130,800,000 JPY
18,000,000 JPY
Proceeds from issuance of shares
JPY
336,172,000 JPY
Repayments of short-term borrowings
-16,500,000 JPY
-13,000,000 JPY
Net cash provided by (used in) financing activities
113,359,000 JPY
341,172,000 JPY
Other, net
0 JPY
JPY
Net increase (decrease) in cash and cash equivalents
-481,839,000 JPY
-319,052,000 JPY
Cash and cash equivalents
1,245,431,000 JPY
1,727,270,000 JPY
1,471,935,000 JPY
1,790,988,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.